Cargando…

External validation of the American prediction model for incident type 2 diabetes in the Iranian population

BACKGROUND: The primary aim of the present study was to validate the REasons for Geographic and Racial Differences in Stroke (REGARDS) model for incident Type 2 diabetes (T2DM) in Iran. METHODS: Present study was a prospective cohort study on 1835 population aged ≥ 45 years from Tehran lipids and gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Asgari, Samaneh, Khalili, Davood, Azizi, Fereidoun, Hadaegh, Farzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053951/
https://www.ncbi.nlm.nih.gov/pubmed/36991336
http://dx.doi.org/10.1186/s12874-023-01891-y
_version_ 1785015535847604224
author Asgari, Samaneh
Khalili, Davood
Azizi, Fereidoun
Hadaegh, Farzad
author_facet Asgari, Samaneh
Khalili, Davood
Azizi, Fereidoun
Hadaegh, Farzad
author_sort Asgari, Samaneh
collection PubMed
description BACKGROUND: The primary aim of the present study was to validate the REasons for Geographic and Racial Differences in Stroke (REGARDS) model for incident Type 2 diabetes (T2DM) in Iran. METHODS: Present study was a prospective cohort study on 1835 population aged ≥ 45 years from Tehran lipids and glucose study (TLGS).The predictors of REGARDS model based on Bayesian hierarchical techniques included age, sex, race, body mass index, systolic and diastolic blood pressures, triglycerides, high-density lipoprotein cholesterol, and fasting plasma glucose. For external validation, the area under the curve (AUC), sensitivity, specificity, Youden’s index, and positive and negative predictive values (PPV and NPV) were assessed. RESULTS: During the 10-year follow-up 15.3% experienced T2DM. The model showed acceptable discrimination (AUC (95%CI): 0.79 (0.76–0.82)), and good calibration. Based on the highest Youden’s index the suggested cut-point for the REGARDS probability would be ≥ 13% which yielded a sensitivity of 77.2%, specificity 66.8%, NPV 94.2%, and PPV 29.6%. CONCLUSIONS: Our findings do support that the REGARDS model is a valid tool for incident T2DM in the Iranian population. Moreover, the probability value higher than the 13% cut-off point is stated to be significant for identifying those with incident T2DM.
format Online
Article
Text
id pubmed-10053951
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100539512023-03-30 External validation of the American prediction model for incident type 2 diabetes in the Iranian population Asgari, Samaneh Khalili, Davood Azizi, Fereidoun Hadaegh, Farzad BMC Med Res Methodol Research BACKGROUND: The primary aim of the present study was to validate the REasons for Geographic and Racial Differences in Stroke (REGARDS) model for incident Type 2 diabetes (T2DM) in Iran. METHODS: Present study was a prospective cohort study on 1835 population aged ≥ 45 years from Tehran lipids and glucose study (TLGS).The predictors of REGARDS model based on Bayesian hierarchical techniques included age, sex, race, body mass index, systolic and diastolic blood pressures, triglycerides, high-density lipoprotein cholesterol, and fasting plasma glucose. For external validation, the area under the curve (AUC), sensitivity, specificity, Youden’s index, and positive and negative predictive values (PPV and NPV) were assessed. RESULTS: During the 10-year follow-up 15.3% experienced T2DM. The model showed acceptable discrimination (AUC (95%CI): 0.79 (0.76–0.82)), and good calibration. Based on the highest Youden’s index the suggested cut-point for the REGARDS probability would be ≥ 13% which yielded a sensitivity of 77.2%, specificity 66.8%, NPV 94.2%, and PPV 29.6%. CONCLUSIONS: Our findings do support that the REGARDS model is a valid tool for incident T2DM in the Iranian population. Moreover, the probability value higher than the 13% cut-off point is stated to be significant for identifying those with incident T2DM. BioMed Central 2023-03-29 /pmc/articles/PMC10053951/ /pubmed/36991336 http://dx.doi.org/10.1186/s12874-023-01891-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Asgari, Samaneh
Khalili, Davood
Azizi, Fereidoun
Hadaegh, Farzad
External validation of the American prediction model for incident type 2 diabetes in the Iranian population
title External validation of the American prediction model for incident type 2 diabetes in the Iranian population
title_full External validation of the American prediction model for incident type 2 diabetes in the Iranian population
title_fullStr External validation of the American prediction model for incident type 2 diabetes in the Iranian population
title_full_unstemmed External validation of the American prediction model for incident type 2 diabetes in the Iranian population
title_short External validation of the American prediction model for incident type 2 diabetes in the Iranian population
title_sort external validation of the american prediction model for incident type 2 diabetes in the iranian population
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053951/
https://www.ncbi.nlm.nih.gov/pubmed/36991336
http://dx.doi.org/10.1186/s12874-023-01891-y
work_keys_str_mv AT asgarisamaneh externalvalidationoftheamericanpredictionmodelforincidenttype2diabetesintheiranianpopulation
AT khalilidavood externalvalidationoftheamericanpredictionmodelforincidenttype2diabetesintheiranianpopulation
AT azizifereidoun externalvalidationoftheamericanpredictionmodelforincidenttype2diabetesintheiranianpopulation
AT hadaeghfarzad externalvalidationoftheamericanpredictionmodelforincidenttype2diabetesintheiranianpopulation